Characterizing Infections in Two Epidemic Waves of SARS-CoV-2 Omicron Variants: A Cohort Study in Guangzhou, China

Author:

Qu Lin123ORCID,Xie Chunyan234,Qiu Ming123,Yi Lina23,Liu Zhe23,Zou Lirong35,Hu Pei5,Jiang Huimin236,Lian Huimin236,Yang Mingda234,Yang Haiyi123,Zeng Huiling237,Chen Huimin234,Zhao Jianguo2,Xiao Jianpeng2,He Jianfeng35,Yang Ying2,Chen Liang2,Li Baisheng35,Sun Jiufeng23,Lu Jing123

Affiliation:

1. School of Public Health, Sun Yat-sen University, Guangzhou 510080, China

2. Guangdong Provincial Institution of Public Health, Guangzhou 511430, China

3. Guangdong Workstation for Emerging Infectious Disease Control and Prevention, Guangdong Provincial Key Laboratory of Pathogen Detection for Emerging Infectious Disease Response, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China

4. School of Basic Medicine and Public Health, Jinan University, Guangzhou 510632, China

5. Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China

6. School of Public Health, Southern Medical University, Guangzhou 510515, China

7. School of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China

Abstract

Background: After the adjustment of COVID-19 epidemic policy, mainland China experienced two consecutive waves of Omicron variants within a seven-month period. In Guangzhou city, as one of the most populous regions, the viral infection characteristics, molecular epidemiology, and the dynamic of population immunity are still elusive. Methods: We launched a prospective cohort study in the Guangdong Provincial CDC from December 2022 to July 2023. Fifty participants who received the same vaccination regimen and had no previous infection were recruited. Results: 90% of individuals were infected with Omicron BA.5* variants within three weeks in the first wave. Thirteen cases (28.26%) experienced infection with XBB.1* variants, occurring from 14 weeks to 21 weeks after the first wave. BA.5* infections exhibited higher viral loads in nasopharyngeal sites compared to oropharyngeal sites. Compared to BA.5* infections, the XBB.1* infections had significantly milder clinical symptoms, lower viral loads, and shorter durations of virus positivity. The infection with the BA.5* variant elicited varying levels of neutralizing antibodies against XBB.1* among different individuals, even with similar levels of BA.5* antibodies. The level of neutralizing antibodies specific to XBB.1* determined the risk of reinfection. Conclusions: The rapid large-scale infections of the Omicron variants have quickly established herd immunity among the population in mainland China. In the future of the COVID-19 epidemic, a lower infection rate but a longer duration can be expected. Given the large population size and ongoing diversified herd immunity, it remains crucial to closely monitor the molecular epidemiology of SARS-CoV-2 for the emergence of new variants of concern in this region. Additionally, the timely evaluation of the immune status across different age groups is essential for informing future vaccination strategies and intervention policies.

Funder

Natural Science Foundation of Guangdong Province

Guangzhou Science and Technology Project

Guangdong Science and Technology Program

Publisher

MDPI AG

Reference32 articles.

1. (2023, December 05). WHO Coronavirus (COVID-19) Dashboard 2023. Available online: https://covid19.who.int.

2. SARS-CoV-2 Variants, Vaccines, and Host Immunity;Mistry;Front. Immunol.,2021

3. Advances in the Omicron variant development;Vitiello;J. Intern. Med.,2022

4. CoronaVac and BBIBP-CorV vaccines against SARS-CoV-2 during predominant circulation of Omicron BA.5.2 and BF.7 in China, a retrospective cohort study;Hu;J. Med. Virol.,2023

5. Modeling transmission of SARS-CoV-2 Omicron in China;Cai;Nat. Med.,2022

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3